<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>786</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12829815</PubmedId>
            <Abstract>The consequences for the long-term maintenance of virus-specific CD8+-T-cell memory have been analyzed experimentally for sequential respiratory infections with readily eliminated (influenza virus) and persistent (gammaherpesvirus 68 [gammaHV68]) pathogens. Sampling a broad range of tissue sites established that the numbers of CD8+ T cells specific for the prominent influenza virus D(b)NP(366) epitope were reduced by about half in mice that had been challenged 100 days previously with gammaHV68, though the prior presence of a large CD8+ D(b)NP366+ population caused no selective defect in the gammaHV68-specific CD8+ K(b)p79+ response. Conversely, mice that had been primed and boosted to generate substantial gammaHV68-specific CD8+ D(b)p56+ populations did not show any decrease in prevalence for this set of CD8+ memory cytotoxic T lymphocytes (CTL) at 200 days after respiratory exposure to an influenza A virus. However, in both experiments, the total magnitude of the CD8+-T-cell pool was significantly diminished in those that had been infected with gammaHV68 and the influenza A virus. The broader implications of these findings, especially under conditions of repeated exposure to unrelated pathogens, are explored with a mathematical model which emphasizes that the immune effector and memory "phenome" is a function of the overall infection experience of the individual.</Abstract>
            <ArticleYear>2003</ArticleYear>
            <ArticlePages>7756-63</ArticlePages>
            <ArticleTitle>Quantitative analysis of long-term virus-specific CD8+-T-cell memory in mice challenged with unrelated pathogens.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Haiyan</ForeName>
                </Author>
                <Author>
                    <LastName>Andreansky</LastName>
                    <ForeName>Samita</ForeName>
                </Author>
                <Author>
                    <LastName>Diaz</LastName>
                    <ForeName>Gabriela</ForeName>
                </Author>
                <Author>
                    <LastName>Turner</LastName>
                    <ForeName>Stephen J</ForeName>
                </Author>
                <Author>
                    <LastName>Wodarz</LastName>
                    <ForeName>Dominik</ForeName>
                </Author>
                <Author>
                    <LastName>Doherty</LastName>
                    <ForeName>Peter C</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Immunology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA.</Affiliations>
            <ArticleMeshHeadingsList>Animals; CD8-Positive T-Lymphocytes(immunology); Female; Gammaherpesvirinae(pathogenicity); Herpesviridae Infections(immunology; virology); Immunologic Memory; Influenza A virus(immunology); Lymphocyte Activation; Mice; Mice, Inbred C57BL; Models, Immunological; Orthomyxoviridae Infections(immunology; virology); Time Factors</ArticleMeshHeadingsList>
            <Journal>
                <Volume>77</Volume>
                <Issue>14</Issue>
                <Title>Journal of virology</Title>
                <Issn>1098-5514</Issn>
                <MedlineTa>J Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>p56</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AGPHNDMEI</LinearSequence>
                        <StartingPosition>487</StartingPosition>
                        <EndingPosition>495</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAK16699.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33708</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 7757</LocationOfData>
                <EpitopeId>1635</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <TCellId>8234</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>33708</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intranasal</Route>
                                <DoseSchedule>1st immunization with immunogen, 6 wk later i.p. with recombinant vaccine virus expressing epitope, and 6wk later intranasally with Influenza A HKx31.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>p56</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AGPHNDMEI</LinearSequence>
                                        <StartingPosition>487</StartingPosition>
                                        <EndingPosition>495</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAK16699.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33708</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No differences in p56 specific CTL numbers are seen in herpes virus infected animals with or without subsequent infection with Influenza A at days 14 and 200 after Influenza infection.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p79</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TSINFKVI</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC244713</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>33708</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 7758</LocationOfData>
                <EpitopeId>66265</EpitopeId>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope in database protein is actually TSINFVKI.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3C</LocationOfData>
                        <TCellId>8239</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>8 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>33708</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1st immunization with immunogen, 6 wk later i.p. with recombinant vaccine virus expressing epitope, and 6wk later intranasally with Influenza A HKx31.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>122</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>p79</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TSINFKVI</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC244713</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>33708</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Higher numbers of peptide specific CD8+ T cells were present in na√Øve mice immunized with the source species than in mice previously infected with Influenza A. A detailed analysis of the organ specific CD8+ cells revealed significant differences only in the liver.  T cells present 100 days after the last immunization were studied.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

